Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study
Burger, Jan A., Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Tedeschi, Alessandra, Bairey, Osnat, Hillmen, Peter, Coutre, Steven E., Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen, Simpson, David, Offner, Fritz, Moreno, Carol, Dai, Sandra, Lal, Indu, Dean, James P., Kipps, Thomas J.
Published in Leukemia (01.03.2020)
Published in Leukemia (01.03.2020)
Get full text
Journal Article
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Dimopoulos, Meletios A, Dytfeld, Dominik, Grosicki, Sebastian, Moreau, Philippe, Takezako, Naoki, Hori, Mitsuo, Leleu, Xavier, LeBlanc, Richard, Suzuki, Kenshi, Raab, Marc S, Richardson, Paul G, Popa McKiver, Mihaela, Jou, Ying-Ming, Shelat, Suresh G, Robbins, Michael, Rafferty, Brian, San-Miguel, Jesús
Published in The New England journal of medicine (08.11.2018)
Published in The New England journal of medicine (08.11.2018)
Get full text
Journal Article
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Lonial, Sagar, Dimopoulos, Meletios, Palumbo, Antonio, White, Darrell, Grosicki, Sebastian, Spicka, Ivan, Walter-Croneck, Adam, Moreau, Philippe, Mateos, Maria-Victoria, Magen, Hila, Belch, Andrew, Reece, Donna, Beksac, Meral, Spencer, Andrew, Oakervee, Heather, Orlowski, Robert Z, Taniwaki, Masafumi, Röllig, Christoph, Einsele, Hermann, Wu, Ka Lung, Singhal, Anil, San-Miguel, Jesus, Matsumoto, Morio, Katz, Jessica, Bleickardt, Eric, Poulart, Valerie, Anderson, Kenneth C, Richardson, Paul
Published in The New England journal of medicine (13.08.2015)
Published in The New England journal of medicine (13.08.2015)
Get full text
Journal Article
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Weisel, Katja, San-Miguel, Jesus, Shpilberg, Ofer, Grosicki, Sebastian, Špička, Ivan, Walter-Croneck, Adam, Magen, Hila, Mateos, Maria-Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Spencer, Andrew, Oakervee, Heather, Orlowski, Robert Z., Taniwaki, Masafumi, Röllig, Christoph, Einsele, Hermann, Matsumoto, Morio, Wu, Ka Lung, Anderson, Kenneth C., Jou, Ying-Ming, Ganetsky, Alex, Singhal, Anil K., Richardson, Paul G.
Published in Blood cancer journal (New York) (04.09.2020)
Published in Blood cancer journal (New York) (04.09.2020)
Get full text
Journal Article
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Chanan-Khan, Asher, Prof, Cramer, Paula, MD, Demirkan, Fatih, MD, Fraser, Graeme, MD, Silva, Rodrigo Santucci, MD, Grosicki, Sebastian, Prof, Pristupa, Aleksander, MD, Janssens, Ann, MD, Mayer, Jiri, Prof, Bartlett, Nancy L, Prof, Dilhuydy, Marie-Sarah, MD, Pylypenko, Halyna, MD, Loscertales, Javier, MD, Avigdor, Abraham, MD, Rule, Simon, Prof, Villa, Diego, MD, Samoilova, Olga, MD, Panagiotidis, Panagiots, Prof, Goy, Andre, MD, Mato, Anthony, MD, Pavlovsky, Miguel A, MD, Karlsson, Claes, MD, Mahler, Michelle, MD, Salman, Mariya, PhD, Sun, Steven, PhD, Phelps, Charles, MS, Balasubramanian, Sriram, PhD, Howes, Angela, PhD, Hallek, Michael, MD
Published in The lancet oncology (01.02.2016)
Published in The lancet oncology (01.02.2016)
Get full text
Journal Article
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
Barr, Paul M, Robak, Tadeusz, Owen, Carolyn, Tedeschi, Alessandra, Bairey, Osnat, Bartlett, Nancy L, Burger, Jan A, Hillmen, Peter, Coutre, Steven, Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen, Li, Jianyong, Simpson, David, Offner, Fritz, Moreno, Carol, Zhou, Cathy, Styles, Lori, James, Danelle, Kipps, Thomas J, Ghia, Paolo
Published in Haematologica (Roma) (01.09.2018)
Published in Haematologica (Roma) (01.09.2018)
Get full text
Journal Article
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
Hillmen, Peter, Prof, Robak, Tadeusz, MD, Janssens, Ann, MD, Babu, K Govind, MD, Kloczko, Janusz, MD, Grosicki, Sebastian, MD, Doubek, Michael, MD, Panagiotidis, Panagiotis, MD, Kimby, Eva, MD, Schuh, Anna, MD, Pettitt, Andrew R, MRCPath, Boyd, Thomas, MD, Montillo, Marco, MD, Gupta, Ira V, MD, Wright, Oliver, BSc, Dixon, Iestyn, BSc, Carey, Jodi L, RN BSN, Chang, Chai-Ni, MS, Lisby, Steen, MD, McKeown, Astrid, PhD, Offner, Fritz, MD
Published in The Lancet (British edition) (09.05.2015)
Published in The Lancet (British edition) (09.05.2015)
Get full text
Journal Article
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Moreau, Philippe, Prof, Pylypenko, Halyna, MD, Grosicki, Sebastian, MD, Karamanesht, Ievgenii, MD, Leleu, Xavier, MD, Grishunina, Maria, MD, Rekhtman, Grigoriy, MD, Masliak, Zvenyslava, MD, Robak, Tadeusz, Prof, Shubina, Anna, MD, Arnulf, Bertrand, MD, Kropff, Martin, MD, Cavet, James, MBBS, Esseltine, Dixie-Lee, MD, Feng, Huaibao, PhD, Girgis, Suzette, PhD, van de Velde, Helgi, MD, Deraedt, William, MSc, Harousseau, Jean-Luc, Prof
Published in The lancet oncology (01.05.2011)
Published in The lancet oncology (01.05.2011)
Get full text
Journal Article
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study
van Oers, Marinus H J, Prof, Kuliczkowski, Kazimierz, Prof, Smolej, Lukáš, MD, Petrini, Mario, Prof, Offner, Fritz, Prof, Grosicki, Sebastian, MD, Levin, Mark-David, MD, Gupta, Ira, MD, Phillips, Jennifer, PhD, Williams, Vanessa, MS, Manson, Stephanie, PhD, Lisby, Steen, MD, Geisler, Christian, Prof
Published in The lancet oncology (01.10.2015)
Published in The lancet oncology (01.10.2015)
Get full text
Journal Article
Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study
HOLOWIECKI, Jerzy, GROSICKI, Sebastian, KLOCZKO, Janusz, JEDRZEJCZAK, Wieslaw W, ZDZIARSKA, Barbara, WARZOCHA, Krzysztof, ZAWILSKA, Krystyna, KOMARNICKI, Mieczysław, KIELBINSKI, Marek, PIATKOWSKA-JAKUBAS, Beata, WIERZBOWSKA, Agnieszka, WACH, Malgorzata, GIEBEL, Sebastian, HAUS, Olga, ROBAK, Tadeusz, KYRCZ-KRZEMIEN, Slawomira, KULICZKOWSKI, Kazimierz, SKOTNICKI, Aleksander B, HELLMANN, Andrzej, SULEK, Kazimierz, DMOSZYNSKA, Anna
Published in Journal of clinical oncology (10.07.2012)
Published in Journal of clinical oncology (10.07.2012)
Get full text
Journal Article
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma
ARNULF, Bertrand, PYLYPENKO, Halyna, GROSICKI, Sebastian, KARAMANESHT, Levgenii, LELEU, Xavier, DE VELDE, Helgi Van, FENG, Huaibao, CAKANA, Andrew, DERAEDT, William, MOREAU, Philippe
Published in Haematologica (Roma) (01.12.2012)
Published in Haematologica (Roma) (01.12.2012)
Get full text
Journal Article
Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
Usmani, Saad Z, Nahi, Hareth, Legiec, Wojciech, Grosicki, Sebastian, Vorobyev, Vladimir, Spicka, Ivan, Hungria, Vania, Korenkova, Sibirina, Bahlis, Nizar J, Flogegard, Max, Bladé, Joan, Moreau, Philippe, Kaiser, Martin, Iida, Shinsuke, Laubach, Jacob, Magen, Hila, Cavo, Michele, Hulin, Cyrille, White, Darrell, De Stefano, Valerio, Lantz, Kristen, O'Rourke, Lisa, Heuck, Christoph, Delioukina, Maria, Qin, Xiang, Nnane, Ivo, Qi, Ming, Mateos, Maria-Victoria
Published in Haematologica (Roma) (01.10.2022)
Published in Haematologica (Roma) (01.10.2022)
Get full text
Journal Article
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Dimopoulos, Meletios A., Dytfeld, Dominik, Grosicki, Sebastian, Moreau, Philippe, Takezako, Naoki, Hori, Mitsuo, Leleu, Xavier, LeBlanc, Richard, Suzuki, Kenshi, Raab, Marc S., Richardson, Paul G., Popa McKiver, Mihaela, Jou, Ying-Ming, Shelat, Suresh G., Robbins, Michael, Rafferty, Brian, San-Miguel, Jesús
Published in The New England journal of medicine (08.11.2018)
Published in The New England journal of medicine (08.11.2018)
Get full text
Journal Article
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial
Knop, Stefan, Mateos, Maria-Victoria, Dimopoulos, Meletios A, Suzuki, Kenshi, Jakubowiak, Andrzej, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Usenko, Ganna, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Losava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Wang, Jianping, Wroblewski, Susan, Kudva, Anupa, Gries, Katharine S, Fastenau, John, San-Miguel, Jesus, Cavo, Michele
Published in BMC cancer (02.06.2021)
Published in BMC cancer (02.06.2021)
Get full text
Journal Article
PB2131: MAGNETISMM‐7: AN OPEN‐LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST‐TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Manteca, Maria Victoria Mateos, Grosicki, Sebastian, Kim, Kihyun, Negre, Eric, Vandendries, Erik
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial
Robak, Tadeusz, Warzocha, Krzysztof, Govind Babu, K., Kulyaba, Yaroslav, Kuliczkowski, Kazimierz, Abdulkadyrov, Kudrat, Loscertales, Javier, Kryachok, Iryna, Kłoczko, Janusz, Rekhtman, Grygoriy, Homenda, Wojciech, Błoński, Jerzy Z., McKeown, Astrid, Gorczyca, Michele M., Carey, Jodi L., Chang, Chai-Ni, Lisby, Steen, Gupta, Ira V., Grosicki, Sebastian
Published in Leukemia & lymphoma (04.05.2017)
Published in Leukemia & lymphoma (04.05.2017)
Get full text
Journal Article
Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies
Topp, Max, Dlugosz-Danecka, Monika, Skotnicki, Aleksander B, Salogub, Galina, Viardot, Andreas, Klein, Andreas K, Hess, Georg, Michel, Christian S, Grosicki, Sebastian, Gural, Alex, Schwarz, Sylvia E, Pietzko, Kerstin, Gärtner, Ulrike, Strassz, András, Alland, Leila, Mayer, Jiri
Published in Current controlled trials in cardiovascular medicine (03.01.2023)
Published in Current controlled trials in cardiovascular medicine (03.01.2023)
Get full text
Journal Article
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen
Libura, Marta, Bialopiotrowicz, Emilia, Giebel, Sebastian, Wierzbowska, Agnieszka, Roboz, Gail J., Piatkowska-Jakubas, Beata, Pawelczyk, Marta, Gorniak, Patryk, Borg, Katarzyna, Wojtas, Magdalena, Florek, Izabella, Matiakowska, Karolina, Jazwiec, Bozena, Solarska, Iwona, Noyszewska-Kania, Monika, Piechna, Karolina, Zawada, Magdalena, Czekalska, Sylwia, Salamanczuk, Zoriana, Karabin, Karolina, Wasilewska, Katarzyna, Paluszewska, Monika, Urbanowska, Elzbieta, Gajkowska-Kulik, Justyna, Semenczuk, Grazyna, Rybka, Justyna, Wrobel, Tomasz, Ejduk, Anna, Kata, Dariusz, Grosicki, Sebastian, Robak, Tadeusz, Pluta, Agnieszka, Kominek, Agata, Piwocka, Katarzyna, Pyziak, Karolina, Sroka-Porada, Agnieszka, Wrobel, Anna, Przybylowicz, Agnieszka, Wojtaszewska, Marzena, Lewandowski, Krzysztof, Gil, Lidia, Piekarska, Agnieszka, Knopinska, Wanda, Bolkun, Lukasz, Warzocha, Krzysztof, Kuliczkowski, Kazimierz, Sacha, Tomasz, Basak, Grzegorz, Jedrzejczak, Wieslaw Wiktor, Holowiecki, Jerzy, Juszczynski, Przemysław, Haus, Olga
Published in Scientific reports (11.05.2021)
Published in Scientific reports (11.05.2021)
Get full text
Journal Article
PB2130: MAGNETISMM‐6: A PHASE 3 STUDY OF ELRANATAMAB + DARATUMUMAB + LENALIDOMIDE VS DARATUMUMAB + LENALIDOMIDE + DEXAMETHASONE IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Grosicki, Sebastian, Yeh, Su‐Peng, Huang, Shang‐Yi, Byun, Ja Min, Dirienzo, Christine, Viqueira, Andrea
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Mateos, Maria V, Gavriatopoulou, Maria, Facon, Thierry, Auner, Holger W, Leleu, Xavier, Hájek, Roman, Dimopoulos, Meletios A, Delimpasi, Sosana, Simonova, Maryana, Špička, Ivan, Pour, Ludĕk, Kriachok, Iryna, Pylypenko, Halyna, Doronin, Vadim, Usenko, Ganna, Benjamin, Reuben, Dolai, Tuphan K, Sinha, Dinesh K, Venner, Christopher P, Garg, Mamta, Stevens, Don A, Quach, Hang, Jagannath, Sundar, Moreau, Philippe, Levy, Moshe, Badros, Ashraf Z, Anderson, Jr, Larry D, Bahlis, Nizar J, Cavo, Michele, Chai, Yi, Jeha, Jacqueline, Arazy, Melina, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G, Richardson, Paul G, Grosicki, Sebastian
Published in Journal of hematology and oncology (13.04.2021)
Published in Journal of hematology and oncology (13.04.2021)
Get full text
Journal Article